📢CALL FOR PAPERS!!
@Biomed_MDPI
🧫🧬Recent Advances of Receptor Tyrosine Kinases in Solid Tumors 🩻
Editor:
@PKaboli
🥇Authors can discuss with me to find a hot topic for planned reviews.
More details ➡️ https://t.co/PGA3OnPeAc
#Cancer#Targeteddrugs#CancerResearch
👉👉👉 You are invited to write a comprehensive review on receptor tyrosine kinase signaling in solid tumors in the next 6 months,
submit it to this Special Issue at @MDPIOpenAccess#Biomedicines (impact factor= 4.757)
https://t.co/umgtYOcPhQ
#aacr#cancer#cancerresearch
In a Review now published online, Guilherme Harada, Soo-Ryum Yang, @emilianoCocco2 and @alexdrilon discuss some molecular subtypes of #lungcancer that, despite occurring in <5% of patients with this cancer type, affect a considerable number of individuals https://t.co/ECSkUEaqZR
📢CALL FOR PAPERS!!
@Biomed_MDPI
🧫🧬Recent Advances of Receptor Tyrosine Kinases in Solid Tumors 🩻
Editors:
@PKaboli
Submit your abstract to this Special Issue!
More details ➡️➡️➡️ https://t.co/PGA3OnPeAc
#Cancer#aacr#CancerResearch#breastcancer
PLEASE RT‼️
Call for submission
I am serving as the Guest Editor of this special issue at Biomedicines, Impact Factor= 4.757,
on “Recent Advances of Receptor Tyrosine Kinases in Solid Tumors”
Read more:
https://t.co/umgtYOcPhQ
#journal#cancer#cancerresearch#mdanderson#aacr
Was applying for U.S. citizenship on your list of resolutions for 2022? If it is and you have not already begun the process, it’s not too late! Use our eligibility tool to determine your eligibility online before creating an account. Get started today: